Stock Analiz

AtriCure, Inc. (ATRC) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

AtriCure’s revenue went from $155M in fiscal 2016 to $535M in fiscal 2025, growth of about 14.7% a year.

Net income in fiscal 2025 was -$11M, a net margin of -2.1%; the best year in this period was 2021 with $50M.

Over the twelve months to September 30, 2026, revenue was $590M and net income $15M.

Free cash flow was $48M in fiscal 2025 and positive in 2 of the 10 years shown.

The diluted share count rose 51% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $155M162017: $175M172018: $202M182019: $231M192020: $207M202021: $274M212022: $330M222023: $399M232024: $465M242025: $535M25$535M
Net income
2016: -$33M162017: -$27M172018: -$21M182019: -$35M192020: -$48M202021: $50M212022: -$46M222023: -$30M232024: -$45M242025: -$11M25-$11M
Free cash flow
2016: -$23M162017: -$15M172018: -$10M182019: -$28M192020: -$25M202021: -$24M212022: -$39M222023: -$8M232024: $745000242025: $48M25$48M
EPS (diluted)
2016: $-1.05162017: $-0.83172018: $-0.62182019: $-0.94192020: $-1.14202021: $1.09212022: $-1.02222023: $-0.66232024: $-0.95242025: $-0.2425$-0.24

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$590M$535M$465M$399M$330M$274M$207M$231M$202M$175M$155M
Gross profit$453M$401M$348M$300M$246M$206M$149M$170M$147M$126M$111M
Operating income$17M-$9M-$40M-$27M-$43M$55M-$44M-$33M-$17M-$25M-$31M
Net income$15M-$11M-$45M-$30M-$46M$50M-$48M-$35M-$21M-$27M-$33M
EPS (diluted)$0.30$-0.24$-0.95$-0.66$-1.02$1.09$-1.14$-0.94$-0.62$-0.83$-1.05
R&D$107M$99M$96M$74M$57M$49M$43M$41M$35M$34M$36M
Revenue growth—+14.9%+16.6%+20.8%+20.4%+32.8%−10.5%+14.5%+15.4%+12.6%+19.5%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$69M$57M$12M$4M-$22M-$14M-$20M-$16M-$4M-$9M-$15M
Capital spending-$16M-$9M-$11M-$12M-$17M-$10M-$5M-$12M-$6M-$6M-$8M
Free cash flow$53M$48M$745000-$8M-$39M-$24M-$25M-$28M-$10M-$15M-$23M
Dividends paid$0$0$0$0$0$0$0$0$0$0$0
Buybacks———————————
Stock-based pay$47M$45M$40M$36M$29M$28M$23M$18M$16M$15M$12M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$167M$123M$137M$121M$119M$244M$82M$124M$34M$44M
Debt—$69M$71M$68M$67M$65M$62M$64M$53M$37M$39M
Equity—$492M$461M$466M$457M$484M$412M$247M$249M$161M$168M
Total assets—$654M$609M$614M$585M$615M$715M$558M$357M$268M$276M
Shares (diluted)50M48M47M46M46M46M42M38M34M32M32M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin76.7%75.0%74.7%75.2%74.4%75.0%72.3%73.8%73.0%72.2%71.6%
Operating margin2.9%-1.8%-8.6%-6.7%-12.9%20.1%-21.4%-14.3%-8.5%-14.3%-20.1%
Net margin2.5%-2.1%-9.6%-7.6%-14.1%18.3%-23.3%-15.2%-10.5%-15.4%-21.5%
FCF margin9.0%9.0%0.2%-1.9%-11.8%-8.6%-12.2%-12.1%-5.1%-8.8%-14.7%
ROIC—-1.3%-5.9%-4.0%-6.4%10.0%-7.4%-8.4%-4.5%-9.9%-11.9%
ROE—-2.3%-9.7%-6.5%-10.2%10.4%-11.7%-14.2%-8.5%-16.7%-19.8%

Frequently asked questions

What is AtriCure’s annual revenue?

$535M in fiscal 2025 and $590M over the twelve months to September 30, 2026.

How much profit does AtriCure make?

Net income was -$11M in fiscal 2025 (net margin -2.1%).

Is AtriCure’s revenue growing?

Yes: revenue rose 14.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.